Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity.

Saved in:
Bibliographic Details
Title: Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity.
Authors: Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Ferraris CE; College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL., De Avila G; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Scheiber-Camoretti D; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Gudenkauf LM; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Small BJ; School of Nursing, The University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, NC., Gonzalez BD; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Nguyen O; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Parker N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Vinci CE; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Baz RC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Blue B; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Grajales-Cruz AF; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Matte K; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kale B; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kaldas D; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Perna F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Castaneda Puglianini O; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Liu H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Peres LC; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL.
Source: Blood advances [Blood Adv] 2026 Mar 24; Vol. 10 (6), pp. 1959-1963.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025018951